Geode Capital Management LLC decreased its holdings in American Vanguard Co. (NYSE:AVD – Free Report) by 0.5% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 581,973 shares of the basic materials company’s stock after selling 2,832 shares during the quarter. Geode Capital Management LLC owned 2.02% of American Vanguard worth $3,085,000 at the end of the most recent reporting period.
Other institutional investors have also recently bought and sold shares of the company. Empowered Funds LLC raised its position in shares of American Vanguard by 5.2% in the third quarter. Empowered Funds LLC now owns 64,915 shares of the basic materials company’s stock valued at $344,000 after buying an additional 3,216 shares in the last quarter. Point72 DIFC Ltd raised its holdings in American Vanguard by 195.7% in the 2nd quarter. Point72 DIFC Ltd now owns 5,080 shares of the basic materials company’s stock valued at $44,000 after acquiring an additional 3,362 shares in the last quarter. Quantbot Technologies LP lifted its position in shares of American Vanguard by 64.5% during the 3rd quarter. Quantbot Technologies LP now owns 11,291 shares of the basic materials company’s stock valued at $60,000 after acquiring an additional 4,429 shares during the period. American Century Companies Inc. grew its holdings in shares of American Vanguard by 12.9% during the 2nd quarter. American Century Companies Inc. now owns 45,206 shares of the basic materials company’s stock worth $389,000 after purchasing an additional 5,170 shares in the last quarter. Finally, SG Americas Securities LLC bought a new position in shares of American Vanguard in the third quarter worth $56,000. Institutional investors own 79.04% of the company’s stock.
American Vanguard Trading Up 0.2 %
Shares of AVD opened at $4.65 on Tuesday. The company has a debt-to-equity ratio of 0.55, a quick ratio of 0.79 and a current ratio of 1.89. American Vanguard Co. has a 52-week low of $4.26 and a 52-week high of $14.28. The firm has a market cap of $133.86 million, a price-to-earnings ratio of -4.51 and a beta of 0.91. The business’s fifty day moving average is $5.40 and its 200-day moving average is $6.30.
Insider Buying and Selling at American Vanguard
Analysts Set New Price Targets
Separately, StockNews.com upgraded shares of American Vanguard from a “sell” rating to a “hold” rating in a research note on Wednesday, September 25th. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $16.67.
Check Out Our Latest Research Report on AVD
About American Vanguard
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.
Featured Articles
- Five stocks we like better than American Vanguard
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Build-Your-Bowl Battle: CAVA, Chipotle, and Sweetgreen Face Off
- What Are Treasury Bonds?
- Insiders Are Loading Up: 3 Key Stock Picks for Investors
- Insider Buying Explained: What Investors Need to Know
- How Cigna Remains at the Top of the Health Insurance Food Chain
Want to see what other hedge funds are holding AVD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for American Vanguard Co. (NYSE:AVD – Free Report).
Receive News & Ratings for American Vanguard Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Vanguard and related companies with MarketBeat.com's FREE daily email newsletter.